Philadelphia Trust Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.54M Buy
30,853
+2,068
+7% +$482K 0.53% 44
2025
Q4
$5.96M Sell
28,785
-105
-0.4% -$20.8K 0.41% 48
2025
Q3
$5.36M Buy
28,890
+1,550
+6% +$266K 0.38% 49
2025
Q2
$4.18M Hold
27,340
0.32% 59
2025
Q1
$4.53M Sell
27,340
-1,368
-5% -$214K 0.39% 54
2024
Q4
$4.15M Sell
28,708
-1,605
-5% -$249K 0.3% 63
2024
Q3
$4.91M Sell
30,313
-96
-0.3% -$15.3K 0.36% 61
2024
Q2
$4.45M Buy
30,409
+243
+0.8% +$36.1K 0.35% 60
2024
Q1
$4.77M Buy
30,166
+4,983
+20% +$793K 0.38% 62
2023
Q4
$3.95M Sell
25,183
-175
-0.7% -$26.8K 0.37% 63
2023
Q3
$3.95M Sell
25,358
-363
-1% -$59.9K 0.41% 62
2023
Q2
$4.26M Sell
25,721
-1,105
-4% -$178K 0.4% 63
2023
Q1
$4.16M Sell
26,826
-660
-2% -$107K 0.42% 64
2022
Q4
$4.86M Sell
27,486
-1,069
-4% -$185K 0.52% 58
2022
Q3
$4.67M Buy
28,555
+20
+0.1% +$3.38K 0.53% 54
2022
Q2
$5.07M Buy
28,535
+12
+0% +$2.14K 0.52% 51
2022
Q1
$5.05M Buy
28,523
+37
+0.1% +$6.3K 0.4% 58
2021
Q4
$4.87M Sell
28,486
-1,000
-3% -$164K 0.35% 58
2021
Q3
$4.76M Sell
29,486
-85
-0.3% -$14.5K 0.35% 60
2021
Q2
$4.87M Sell
29,571
-1,136
-4% -$188K 0.34% 65
2021
Q1
$5.05M Buy
30,707
+3,325
+12% +$538K 0.39% 62
2020
Q4
$4.31M Buy
27,382
+303
+1% +$44.7K 0.35% 63
2020
Q3
$4.03M Buy
27,079
+250
+0.9% +$37K 0.39% 55
2020
Q2
$3.77M Sell
26,829
-3,885
-13% -$566K 0.4% 54
2020
Q1
$4.03M Sell
30,714
-4,045
-12% -$574K 0.51% 48
2019
Q4
$5.07M Sell
34,759
-600
-2% -$81.4K 0.43% 66
2019
Q3
$4.58M Buy
35,359
+4,725
+15% +$623K 0.42% 66
2019
Q2
$4.27M Sell
30,634
-2,173
-7% -$301K 0.38% 68
2019
Q1
$4.59M Buy
32,807
+18,050
+122% +$2.42M 0.4% 63
2018
Q4
$1.9M Sell
14,757
-1,740
-11% -$243K 0.2% 76
2018
Q3
$2.28M Buy
16,497
+1,415
+9% +$188K 0.19% 83
2018
Q2
$1.83M Sell
15,082
-335
-2% -$41.8K 0.16% 88
2018
Q1
$1.98M Sell
15,417
-1,538
-9% -$208K 0.16% 91
2017
Q4
$2.37M Buy
16,955
+184
+1% +$25.6K 0.19% 83
2017
Q3
$2.18M Sell
16,771
-35
-0.2% -$4.64K 0.18% 87
2017
Q2
$2.22M Buy
16,806
+269
+2% +$34.3K 0.19% 89
2017
Q1
$2.06M Buy
16,537
+2,358
+17% +$282K 0.17% 94
2016
Q4
$1.63M Buy
14,179
+846
+6% +$97.7K 0.13% 103
2016
Q3
$1.57M Buy
13,333
+1,599
+14% +$194K 0.14% 100
2016
Q2
$1.42M Hold
11,734
0.12% 99
2016
Q1
$1.27M Buy
11,734
+325
+3% +$33.6K 0.11% 96
2015
Q4
$1.16M Sell
11,409
-619
-5% -$62.3K 0.1% 102
2015
Q3
$1.12M Buy
12,028
+11,166
+1,295% +$1.08M 0.1% 98
2015
Q2
$8.85K Sell
862
-8,366
-91% -$838K 0.03% 145
2015
Q1
$928K Buy
9,228
+87
+1% +$8.85K 0.07% 118
2014
Q4
$956K Buy
9,141
+500
+6% +$52.7K 0.08% 101
2014
Q3
$921K Sell
8,641
-3,000
-26% -$311K 0.06% 110
2014
Q2
$1.22M Sell
11,641
-275
-2% -$27.8K 0.08% 94
2014
Q1
$1.17M Buy
11,916
+1,017
+9% +$94.3K 0.07% 101
2013
Q4
$998K Buy
10,899
+325
+3% +$30K 0.06% 112
2013
Q3
$917K Sell
10,574
-542
-5% -$48.6K 0.06% 111
2013
Q2
$954K Buy
+11,116
New +$943K 0.07% 110

Other funds holding JNJ

Philadelphia Trust Company's JNJ Position: Q1 2026 in Review

Philadelphia Trust Company increased its Johnson & Johnson (JNJ) stake by 7.2% in Q1 2026, buying an estimated $482K and bringing the position to 30,853 shares worth $7.54M. The position accounts for 0.53% of the portfolio, ranked #44.

Philadelphia Trust Company first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Philadelphia Trust Company held 30,853 shares of Johnson & Johnson worth $7.54M as of Q1 2026.
  • Philadelphia Trust Company bought 2,068 Johnson & Johnson shares in Q1 2026, an estimated $482K.
  • Johnson & Johnson made up 0.53% of Philadelphia Trust Company's portfolio in Q1 2026, its #44 holding.
  • Philadelphia Trust Company first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Philadelphia Trust Company's 13F filing for Q1 2026, filed 13 May 2026.